Aflac traded at $120.47 this Monday July 6th, decreasing $0.41 or 0.34 percent since the previous trading session. Looking back, over the last four weeks, Aflac lost 4.54 percent. Over the last 12 months, its price rose by 17.10 percent. Looking ahead, we forecast Aflac to be priced at 118.35 by the end of this quarter and at 111.09 in one year, according to Trading Economics global macro models projections and analysts expectations.
Aflac Incorporated is a holding company. The Company is involved in supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac). The Company's insurance business consists of two segments: Aflac Japan and Aflac U.S. Aflac Japan are designed to help consumers pay for medical and non-medical costs that are not reimbursed under Japan's national health insurance system. It offers insurance products, such as cancer, medical, and income support insurance. Its protection products include whole life, GIFT, and WAYS and Child Endowment. The Company designs the United States insurance products to provide supplemental coverage for people having medical or primary insurance coverage. Aflac U.S. offers accident coverage on both an individual and group basis. It offers cancer plans, critical illness plans, and critical care and recovery plans.